Loading...
 
Επιστροφή στη λίστα
Article Links
Αμφοτερόπλευρο οίδημα χειρών με εντύπωμα σε ηλικιωμένο ασθενή: Παρουσίαση τυπικής περίπτωσης συνδρόμου RS3PE και ανασκόπηση βιβλιογραφίας
Δημήτριος Καρόκης
Πληροφορίες Συγγραφέων

Ιδιώτης ρευματολόγος, Πάτρα.

Λέξεις Κλειδιά: Σύνδρομο Υφέσιμης Οροαρνητικής Συμμετρικής Υμενίτιδας με Οίδημα με εντύπωμα, RS3PE.
Παραπομπές
  1. McCarthy D J, O’Duffy D J, Pearson L, et al. Remitting Seronegative Symmetrical Synovitis with Pitting oedema. RS3PE Syndrome. JAMA 1985;254:2763-7.
  2. Karmacharya P, Donato A A, Aryal M R, Ghimire S, Pathak P, Shah K, et al. RS3PE revisited. A systematic review and meta-analysis of 331 cases. Clin Exp Rheum 2016;34:404-15.
  3. Salam A, Rafik H, Sheeran T: Acute onset polyarthritis in older people. Is it RS3PE syndrome? Cases Journal 2008;1:132
  4. Olive A, del Bianco J, Pons M, Vaquero M, Tena X. The clinical spectrum of remitting seronegative symmetrical synovitis with pitting oedema. The Catalan Group for the Study of RS3PE. J Rheumatology 1997;24:333-6.
  5. Dudler J, Gerster J C, So A. Polyarthritis and pitting oedema. Ann Rheum Dis 1999;58:142-7.
  6. Shaeverbeke T, Vernhes J P, Bannwarth B, Dehais J. Is remitting seronegative symmetrical synovitis with pitting oedema (RS3PE syndrome) associated with HLA-A2? Br J Rheumatology 1995;34:889-890.
  7. Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M, et al. RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis 2005;64:1653-5.
  8. Roblot P, Zaim A, Azais I, et al. RS3PE: A clinical diagnosis, a prognosis more simple than its name. Rev Med Interne 1998;19:542-7.
  9. Russell E B, Hunter J B, L Pearson, et al. Remitting, seronegative, symmetrical synovitis with pitting oedema- 13 additional cases. J Rheumatol 1990;17:633-9.
  10. Healey L A. RS3PE syndrome. J Rheumatol 1990;17:414.
  11. Kimura M, Tokuda Y, Oshiawa H, et al. Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting oedema compared to patients with pure polymyalgia rheumatica. J Rheumatol 2012;39:148-53.
  12. Dasgupta B, Cimmino M A, Cremers H M, Schmidt W A, Schirmer M, Salvarani C, et al. 2012 provision classification criteria for polymyalgia rheumatica: A European League Against Rheumatology/American College of Rheumatology collaborative initiative. Arthritis Rheum 2012 Apr;64:943-54.
  13. Agarwal V, Dabra A K, Kaur R, et al. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: Ultrasonography as a diagnostic tool. Clin Rheumatol 2005;24:476-9.
  14. Cantini F, Salvarani C, Olivieri I. Paraneoplastic remitting seronegative symmetrical synovitis. Clin Exp Rheumatol 1999;17:741-4.
  15. Sayarlioglu M. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome and malignancy. Eur J Ger Med 2004;1:3-5.
  16. Smitten A L, Simon T A, Hochberg M C, et al. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthr Res Ther 2008;10:R45.
  17. Manger B, Schett G. Araneoplastic syndromes in Rheumatology. Nature Rev Rheumatology 2014;10:662-70.
  18. Shaeverbeke T, Fatout E, Marce S, Vernhes J P, Halle O, Antoine J F, et al. Remitting seronegative symmetrical synovitis with pitting oedema: disease or syndrome? Ann Rheum Dis 1995;54:681-4.
  19. Paira S, Graf C, Roverano S, et al. Remitting seronegative symmetrical synovitis with pitting oedema: A study of 12 cases. Clin Rheumatol 2002;21:146-9.
  20. Calis M, Cuce I, Akgul O, Cuce E G, Candan V. The treatment approach for the remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome. Doi:100136/annrheumdis-2015-eular.3312.
  21. Izumi K, Kuda H, Ushikubo M, Kuwana M, Takeuchi T, Oshima H. Tocilizumab is effective against polymyalgia rheumatica. Experience in 13 intractable cases. RMD Open 2015;1:e000162.
  22. Furst D, Fleishman R, Kalden J, Kavanaugh A, Sieper J, Mease P, et al. Documentation of off-label use of biologics in Rheumatoid Arthritis. Ann Rheum Dis 2013;72:ii35-ii51.
  23. Mehta P, Chong S, Carulli M, Haskaard D. Steroid-resistant remitting seronegative symmetrical synovitis with pitting oedema associated with gout treated with etanercept (letter). Rheumatology 2014;53:1908-10.
  24. Guma M, Casado E, Tena X. RS3PE: Six years later. Ann Rheum Dis 1999;58:722-3.